Cargando…

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

OBJECTIVE: To update the European League Against Rheumatism (EULAR) recommendations for the pharmacological treatment of psoriatic arthritis (PsA). METHODS: According to the EULAR standardised operating procedures, a systematic literature review was followed by a consensus meeting to develop this up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gossec, Laure, Baraliakos, Xenofon, Kerschbaumer, Andreas, de Wit, Maarten, McInnes, Iain, Dougados, Maxime, Primdahl, Jette, McGonagle, Dennis G, Aletaha, Daniel, Balanescu, Andra, Balint, Peter V, Bertheussen, Heidi, Boehncke, Wolf-Henning, Burmester, Gerd R, Canete, Juan D, Damjanov, Nemanja S, Kragstrup, Tue Wenzel, Kvien, Tore K, Landewé, Robert B M, Lories, Rik Jozef Urbain, Marzo-Ortega, Helena, Poddubnyy, Denis, Rodrigues Manica, Santiago Andres, Schett, Georg, Veale, Douglas J, Van den Bosch, Filip E, van der Heijde, Désirée, Smolen, Josef S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Recommendation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286048/ https://www.ncbi.nlm.nih.gov/pubmed/32434812 http://dx.doi.org/10.1136/annrheumdis-2020-217159

Ejemplares similares

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce
por: De Marco, Gabriele, et al.
Publicado: (2023)

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists
por: Gossec, L, et al.
Publicado: (2008)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
por: Smolen, Josef S, et al.
Publicado: (2014)

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
por: Kerschbaumer, Andreas, et al.
Publicado: (2020)

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
por: Buch, Maya H, et al.
Publicado: (2015)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology
por: Dejaco, Christian, et al.
Publicado: (2018)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
por: Braun, J, et al.
Publicado: (2011)

EULAR definition of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2021)

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
por: Sepriano, Alexandre, et al.
Publicado: (2017)

Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)
por: Dougados, Maxime, et al.
Publicado: (2012)

Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
por: Regel, Andrea, et al.
Publicado: (2017)

Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patients
por: Duarte, Catia, et al.
Publicado: (2021)

EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future
por: Alunno, Alessia, et al.
Publicado: (2021)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
por: Alunno, Alessia, et al.
Publicado: (2021)

Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
por: Alunno, Alessia, et al.
Publicado: (2021)

Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider
por: Alunno, Alessia, et al.
Publicado: (2021)

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
por: Gaujoux-Viala, Cécile, et al.
Publicado: (2014)

Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider
por: Najm, Aurélie, et al.
Publicado: (2021)

Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider
por: Unger, Julia, et al.
Publicado: (2018)

A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Involving patients as research partners in research in rheumatology: a literature review in 2023
por: Elhai, Muriel, et al.
Publicado: (2023)

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations
por: Kedra, Joanna, et al.
Publicado: (2019)

Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force
por: Ovseiko, Pavel V, et al.
Publicado: (2022)

Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts
por: Ez-Zaitouni, Zineb, et al.
Publicado: (2017)

Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort
por: Biliavska, Iuliia, et al.
Publicado: (2013)

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
por: Smolen, Josef S, et al.
Publicado: (2018)

American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision
por: Studenic, Paul, et al.
Publicado: (2023)

American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision
por: Studenic, Paul, et al.
Publicado: (2022)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

Mise à jour des recommandations EULAR sur l’utilisation des thérapies immunomodulatrices dans la prise en charge de la Covid-19
por: Najm, A., et al.
Publicado: (2021)

Percentage of progressors in imaging: can we ignore regressors?
por: Sepriano, Alexandre, et al.
Publicado: (2019)

EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative
por: van Onna, Marloes, et al.
Publicado: (2021)

Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
por: van der Heijde, Désirée, et al.
Publicado: (2020)

Flow cytometric characterization of freshly isolated and culture expanded human synovial cell populations in patients with chronic arthritis
por: Van Landuyt, Kristel B, et al.
Publicado: (2010)

EULAR study group on ‘MHC-I-opathy’: identifying disease-overarching mechanisms across disciplines and borders
por: Kuiper, Jonas JW, et al.
Publicado: (2023)

EULAR Kongress-Splitter
por: Bach, Bianca
Publicado: (2021)

Implementation and role of modern musculoskeletal imaging in rheumatological practice in member countries of EULAR
por: Mandl, Peter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j8bprsvcllas5qt547o4buh13d